Skip to content
HowShorted

SkinHealth Systems Inc. Class short interest in 2022

In 2022, SkinHealth Systems Inc. Class's disclosed short interest ran from 11.32% of shares outstanding on 14 Jan 2022 to 19.66% on 30 Dec 2022, a change of +8.34 percentage points. The year's high was 22.88% on 15 Nov 2022 and its low 9.20% on 15 Mar 2022, averaging 13.91% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.10 days on 30 Nov 2022. Full history: SkinHealth Systems Inc. Class.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SkinHealth Systems Inc. Class in 2022

2022 in figures

Start of year
11.32% (14 Jan 2022)
End of year
19.66% (30 Dec 2022)
Change
+8.34 pp
High
22.88% (15 Nov 2022)
Low
9.20% (15 Mar 2022)
Average
13.91%
Highest days to cover
20.10 (30 Nov 2022)
SEC filings marked
8

Every report in 2022

SkinHealth Systems Inc. Class short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202211.32%6.05
31 Jan 202210.34%4.90
15 Feb 20229.98%9.70
28 Feb 20229.60%4.09results (8-K)
15 Mar 20229.20%8.4410-K filed
31 Mar 202210.18%8.39
14 Apr 202210.21%10.49
29 Apr 202211.32%9.65
13 May 202211.75%4.7210-Q filed, results (8-K)
31 May 202211.54%10.91
15 Jun 202213.06%10.79
30 Jun 202212.47%9.33
15 Jul 202212.97%16.66
29 Jul 202213.67%18.01
15 Aug 202212.71%9.6210-Q filed, results (8-K)
31 Aug 202212.25%13.18
15 Sep 202213.09%12.44
30 Sep 202218.79%15.49
14 Oct 202217.68%19.00
31 Oct 202217.18%16.79
15 Nov 202222.88%9.61results (8-K), 10-Q filed
30 Nov 202221.47%20.10
15 Dec 202220.59%16.40
30 Dec 202219.66%15.57

See also: SkinHealth Systems Inc. Class's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.